Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression.
about
The chemokine CCL3 promotes experimental liver fibrosis in mice.Caveolin-1 regulates chemokine receptor 5-mediated contribution of bone marrow-derived cells to dermal fibrosisMet-CCL5 represents an immunotherapy strategy to ameliorate rabies virus infection.Experimental liver fibrosis research: update on animal models, legal issues and translational aspects.Are mast cells instrumental for fibrotic diseases?Hepatitis C virus-induced CCL5 secretion from macrophages activates hepatic stellate cells.
P2860
Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression.
@en
Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression.
@nl
type
label
Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression.
@en
Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression.
@nl
prefLabel
Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression.
@en
Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression.
@nl
P2093
P2860
P1476
Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression.
@en
P2093
Andreas Nellen
Christian Trautwein
Daniel Heinrichs
Frank Tacke
Hacer Sahin
Hermann E Wasmuth
Linda Hammerich
Marie-Luise Berres
Miriam K Stock
Muhammad Alsamman
P2860
P304
P577
2013-03-15T00:00:00Z